Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.phrs.2024.107350 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Commentary on "Apabetalone, a BET protein inhibitor, inhibits kidney damage in diabetes by preventing pyroptosis via modulating the P300/H3K27ac/PLK1 axis".
Pharmacol Res
October 2024
First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, China. Electronic address:
Correspondence: Reply to commentary on "Apabetalone, a BET protein inhibitor, inhibits kidney damage in diabetes by preventing pyroptosis via modulating the P300/H3K27ac/PLK1 axis".
Pharmacol Res
October 2024
Department of Nephrology, First Hospital of China Medical University, Shenyang, Liaoning, China; Department of Nephrology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Electronic address:
Commentary on "Apabetalone, a BET protein inhibitor, inhibits kidney damage in diabetes by preventing pyroptosis via modulating the P300/H3K27ac/PLK1 axis".
Pharmacol Res
November 2024
Hospital, Heilongjiang University of Chinese Medicine, Harbin, China. Electronic address:
Novel Therapeutic Options for Cardiovascular Disease with CKD.
Clin J Am Soc Nephrol
May 2021
Nephrology, Dialysis and Renal Transplantation Unit, Grande Ospedale Metropolitano, Reggio Calabria, Italy.
Epigenetic Therapeutics for Cardiovascular Disease: Writing, Erasing, Reading, and Maybe Forgetting.
JAMA
April 2020
Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!